ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
TauRx global phase 3 trial in Alzheimer's disease with tau aggregation inhibitor LMTX
Neurobiology of Aging
◽
10.1016/j.neurobiolaging.2014.01.128
◽
2014
◽
Vol 35
◽
pp. S26
◽
Cited By ~ 1
Author(s):
Claude M. Wischik
◽
C.R. Harrington
◽
J.M.D. Storey
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Phase 3
◽
Aggregation Inhibitor
◽
Tau Aggregation
Download Full-text
Related Documents
Cited By
References
O4-08-02: Phase 3 Trial of the TAU Aggregation Inhibitor Leuco-Methylthioninium-Bis (Hydromethanesulfonate) (Lmtm) in Mild to Moderate Alzheimer's Disease
Alzheimer s & Dementia
◽
10.1016/j.jalz.2016.06.650
◽
2016
◽
Vol 12
◽
pp. P351-P352
◽
Cited By ~ 3
Author(s):
Serge Gauthier
◽
Howard H. Feldman
◽
Lon S. Schneider
◽
Gordon Wilcock
◽
Giovanni B. Frisoni
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Phase 3
◽
Aggregation Inhibitor
◽
Tau Aggregation
Download Full-text
F1-01-02: Rember: Issues in design of a phase 3 disease modifying clinical trial of Tau aggregation inhibitor therapy in Alzheimer's disease
Alzheimer s & Dementia
◽
10.1016/j.jalz.2009.05.175
◽
2009
◽
Vol 5
(4S_Part_3)
◽
pp. P74-P74
◽
Cited By ~ 7
Author(s):
Claude Wischik
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Clinical Trial
◽
Inhibitor Therapy
◽
Phase 3
◽
Disease Modifying
◽
Aggregation Inhibitor
◽
Tau Aggregation
Download Full-text
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
The Lancet
◽
10.1016/s0140-6736(16)31275-2
◽
2016
◽
Vol 388
(10062)
◽
pp. 2873-2884
◽
Cited By ~ 160
Author(s):
Serge Gauthier
◽
Howard H Feldman
◽
Lon S Schneider
◽
Gordon K Wilcock
◽
Giovanni B Frisoni
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Inhibitor Therapy
◽
Efficacy And Safety
◽
Phase 3
◽
Double Blind
◽
Aggregation Inhibitor
◽
Randomised Controlled
◽
Tau Aggregation
Download Full-text
O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks
Alzheimer s & Dementia
◽
10.1016/j.jalz.2008.05.438
◽
2008
◽
Vol 4
◽
pp. T167-T167
◽
Cited By ~ 70
Author(s):
Claude M. Wischik
◽
Peter Bentham
◽
Damon J. Wischik
◽
Kwang Meng Seng
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Disease Progression
◽
Aggregation Inhibitor
◽
Tau Aggregation
Download Full-text
O1-06-04: Methylthioninium chloride (MTC) acts as a Tau aggregation inhibitor (TAI) in a cellular model and reverses Tau pathology in transgenic mouse models of Alzheimer's disease
Alzheimer s & Dementia
◽
10.1016/j.jalz.2008.05.259
◽
2008
◽
Vol 4
◽
pp. T120-T121
◽
Cited By ~ 13
Author(s):
Charles Harrington
◽
Janet E. Rickard
◽
David Horsley
◽
Kathleen A. Harrington
◽
Kathleen P. Hindley
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Transgenic Mouse
◽
Mouse Models
◽
Cellular Model
◽
Transgenic Mouse Models
◽
Tau Pathology
◽
Methylthioninium Chloride
◽
Aggregation Inhibitor
◽
Tau Aggregation
Download Full-text
Complex Disposition of Methylthioninium Redox Forms Determines Efficacy in Tau Aggregation Inhibitor Therapy for Alzheimer’s Disease
Journal of Pharmacology and Experimental Therapeutics
◽
10.1124/jpet.114.219352
◽
2014
◽
Vol 352
(1)
◽
pp. 110-118
◽
Cited By ~ 67
Author(s):
Thomas C. Baddeley
◽
Jennifer McCaffrey
◽
John M. D. Storey
◽
John K. S. Cheung
◽
Valeria Melis
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Inhibitor Therapy
◽
Aggregation Inhibitor
◽
Tau Aggregation
◽
Redox Forms
Download Full-text
P4-384: Tau Aggregation Inhibitor (TAI) therapy with rember™ changes glucose metabolism in the medial temporal lobes in mild and moderate Alzheimer's disease (AD)
Alzheimer s & Dementia
◽
10.1016/j.jalz.2008.05.2454
◽
2008
◽
Vol 4
◽
pp. T786-T787
◽
Cited By ~ 5
Author(s):
Alison D. Murray
◽
Roger T. Staff
◽
Trevor S. Ahearn
◽
Peter Bentham
◽
Kwang Meng Seng
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Glucose Metabolism
◽
Medial Temporal Lobes
◽
Temporal Lobes
◽
Aggregation Inhibitor
◽
Tau Aggregation
Download Full-text
Tau-aggregation inhibitor therapy for Alzheimer's disease
Biochemical Pharmacology
◽
10.1016/j.bcp.2013.12.008
◽
2014
◽
Vol 88
(4)
◽
pp. 529-539
◽
Cited By ~ 147
Author(s):
Claude M. Wischik
◽
Charles R. Harrington
◽
John M.D. Storey
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Inhibitor Therapy
◽
Aggregation Inhibitor
◽
Tau Aggregation
Download Full-text
P4-347: Tau aggregation inhibitor (TAI) therapy with rember™ arrests the trajectory of rCBF decline in brain regions affected by Tau pathology in mild and moderate Alzheimer's disease (AD)
Alzheimer s & Dementia
◽
10.1016/j.jalz.2008.05.2417
◽
2008
◽
Vol 4
◽
pp. T775-T775
◽
Cited By ~ 6
Author(s):
Roger T. Staff
◽
Trevor S. Ahearn
◽
Alison D. Murray
◽
Peter Bentham
◽
Kwang Meng Seng
◽
...
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Brain Regions
◽
Tau Pathology
◽
Aggregation Inhibitor
◽
Tau Aggregation
Download Full-text
Chapter 11. Rationale for Tau-Aggregation Inhibitor Therapy in Alzheimer's Disease and Other Tauopathies
Drug Discovery - Emerging Drugs and Targets for Alzheimer's Disease
◽
10.1039/9781849731065-00210
◽
2010
◽
pp. 210-232
◽
Cited By ~ 1
Author(s):
Claude M. Wischik
◽
Damon J. Wischik
◽
John M.D. Storey
◽
Charles R. Harrington
Keyword(s):
Alzheimer’S Disease
◽
Alzheimer's Disease
◽
Inhibitor Therapy
◽
Aggregation Inhibitor
◽
Tau Aggregation
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close